Utah Medical Products (UTMD) Equity Average (2016 - 2025)
Historic Equity Average for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to $117.9 million.
- Utah Medical Products' Equity Average fell 502.08% to $117.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year decrease of 502.08%. This contributed to the annual value of $122.9 million for FY2024, which is 130.77% up from last year.
- Utah Medical Products' Equity Average amounted to $117.9 million in Q3 2025, which was down 502.08% from $117.3 million recorded in Q2 2025.
- Utah Medical Products' Equity Average's 5-year high stood at $128.0 million during Q1 2024, with a 5-year trough of $103.9 million in Q1 2021.
- Moreover, its 5-year median value for Equity Average was $117.2 million (2025), whereas its average is $115.7 million.
- In the last 5 years, Utah Medical Products' Equity Average soared by 1382.1% in 2023 and then tumbled by 842.83% in 2025.
- Utah Medical Products' Equity Average (Quarter) stood at $108.6 million in 2021, then rose by 2.45% to $111.2 million in 2022, then grew by 13.3% to $126.0 million in 2023, then fell by 4.12% to $120.8 million in 2024, then decreased by 2.42% to $117.9 million in 2025.
- Its last three reported values are $117.9 million in Q3 2025, $117.3 million for Q2 2025, and $117.2 million during Q1 2025.